Differences in breast carcinoma immunohistochemical subtypes between immigrant Arab and European women

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast cancer among Yemeni women using the National Oncology Centre Registry 2004–2010

(2012) S. El-Zaemey et al.   Cancer Epidemiology

A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas

(2012) Asli Cakir et al.   Diagnostic Pathology

Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco

(2012) Hinde El Fatemi et al.   Diagnostic Pathology

Knowledge, Attitudes, and Beliefs of Arab-American Women Regarding Inherited Cancer Risk

(2012) Suzanne Mellon et al.   Journal of Genetic Counseling

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies

(2011) Anne-Sofie Schrohl et al.   HISTOPATHOLOGY

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004

(2009) C. R. Eheman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION